Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
Conditions: Type 1 Diabetes; Diabetes Mellitus, Type 1 Interventions: Drug: Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®); Drug: Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride) Sponsors: Melbourne Health; National Health and Medical Research Council, Australia; Juvenile Diabetes Research Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abatacept | Australia Health | Chloride | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Orencia | Research | Sodium | Sodium Chloride